Literature DB >> 27708873

The clinical utility of anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

İsmail Şimşek1.   

Abstract

Entities:  

Year:  2014        PMID: 27708873      PMCID: PMC5042276          DOI: 10.5152/eurjrheumatol.2014.024

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


× No keyword cloud information.
  8 in total

1.  Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.

Authors:  Cengiz Korkmaz; Tercan Us; Timuçin Kaşifoğlu; Yurdanur Akgün
Journal:  Clin Biochem       Date:  2006-07-13       Impact factor: 3.281

2.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

3.  Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.

Authors:  Marc C Levesque; Zhijie Zhou; Larry W Moreland
Journal:  Arthritis Rheum       Date:  2009-08

Review 4.  Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis.

Authors:  Penny F Whiting; Nynke Smidt; Jonathan A C Sterne; Roger Harbord; Anya Burton; Margaret Burke; Rebecca Beynon; Yoav Ben-Shlomo; John Axford; Paul Dieppe
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

5.  The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.

Authors:  Yeliz Özkaya Eker; Ömer Nuri Pamuk; Gülsüm Emel Pamuk; Salim Dönmez; Necati Çakır
Journal:  Eur J Rheumatol       Date:  2014-06-01

Review 6.  Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.

Authors:  Walther J van Venrooij; Joyce J B C van Beers; Ger J M Pruijn
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

Authors:  N Inanc; E Dalkilic; S Kamali; E Kasapoglu-Günal; Y Elbir; H Direskeneli; M Inanc
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

Review 8.  Epidemiology and burden of illness of rheumatoid arthritis.

Authors:  Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.